EUVIMEDEUVIMED entdecken
Crossref

Re: Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study

Madhulika L Mahashabde, Sai Karthik Guniganti

Journal of The Association of Physicians of India · 2026-11 · 74 (11) · 85-86

DOI: 10.59556/japi.74.1647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of The Association of Physicians of India, 2026-11. Verfasst von Madhulika L Mahashabde und 1 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mahashabde, M. L., & Guniganti, S. K. (2026). Re: Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study. Journal of The Association of Physicians of India, 74(11), 85-86. https://doi.org/10.59556/japi.74.1647

Vancouver

Mahashabde ML, Guniganti SK. Re: Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study. Journal of The Association of Physicians of India. 2026;74(11):85-86. doi:10.59556/japi.74.1647

BibTeX
@article{Mahashabde2026,
  author = {Mahashabde, Madhulika L and Guniganti, Sai Karthik},
  title = {Re: Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study},
  journal = {Journal of The Association of Physicians of India},
  year = {2026},
  volume = {74},
  number = {11},
  pages = {85--86},
  doi = {10.59556/japi.74.1647}
}
Kostenlos starten →